Authors


Dirk Dhossche, MD, PhD

Latest:

Catatonia in Autism or the Blind Men and the Elephant

Current treatments for autistic spectrum disorders (ASD) are useful in some cases, but have little enduring impact. This had lead to many parents seeking nonconventional treatments that often border on quackery.


Divy Ravindranath, MD, MS

Latest:

Psychiatric Emergency Strategies

Here we present how to assess safely patients who become oppositional or menacing in a clinic or office.


Domeena C. Renshaw, MD

Latest:

Can Dialogue Cure? A Couple's Therapeutic Journey

Individuals with a past history of chronic psychiatric illness are often given poor prognoses that can limit their therapeutic horizons for further treatment. This pessimism may be misplaced as is demonstrated by the case of Jay, age 71, and Kay, age 65. The couple presented at the Loyola Sexual Dysfunction Clinic in a program consisting of 7 weekly sessions of 5 hours each with 2 trainee therapists.


Don Hilty, MD

Latest:

Telepsychiatry for Vulnerable and Underserved Populations

When timely psychiatric care or consultation is difficult or impossible to obtain, telepsychiatry may be an acceptable, economical, and effective alternative.


Don R. Lipsitt, MD

Latest:

Integration Redux

What is integrated care anyway?


Donald B. Penzien, PhD

Latest:

10 Salient Points About Migraine and Psychiatric Comorbidity

Where do migraines and psychiatric disorders intersect? Learn more.


Donald C. Goff, MD

Latest:

Antipsychotics and the Shrinking Brain

Psychosis at any phase of the illness can be extremely distressing, disruptive, and potentially dangerous for patient and family.


Donald E. Greydanus, MD

Latest:

Predicting, Assessing, and Treating Self-Harm in Adolescents

The authors differentiate between 3 types of deliberate self-harm: nonsuicidal self-injury, culturally sanctioned body modifications (tattooing or body piercing), and unintentional or accidental injury.


Donald F. Klein, MD

Latest:

Current Obstacles to Drug Development

While pharmaceutical research in the United States provides for unparalleled high quality of treatment, many drugs already proven effective in other countries may never become available here due to a combination of obstacles.


Donald H. Taylor, DO, DLFAPA

Latest:

Pharmonitor Feedback

Dr Stone’s Pharmonitor essay justly skewers drug promotion hubris disguised as a CME article.


Donald L. Nathanson, MD

Latest:

Narcissistic Leaders: Who Succeeds and Who Fails

Most of what we read confirms the correctness of our approach and technique. Reasonably proud of our successes as clinicians, we blame the illness rather than the patient when we fail.


Donald M. Dougherty, PhD

Latest:

The Conceptualization and Role of Impulsivity: Bipolar Disorder and Substance Abuse

Impulsive behaviors play an important role in both bipolar and substance abuse disorders. However, results of studies investigating this link are often ambiguous, in part, due to the multidimensional nature of the impulsivity construct and the fact that many studies use a single measurement technique. We describe a model of impulsivity characterized by three components: response initiation, response inhibition and consequence sensitivity. How these components differ from one another in terms of their use, behavioral theory and biological function is discussed, along with measurement techniques.


Donald M. Hilty, MD

Latest:

Drug Therapies for the Neurobehavioral Sequelae of Traumatic Brain Injury

Traumatic brain injury (TBI) is one of the most common causes of morbidity and mortality, especially in young adults. Recognition and early accurate diagnosis of neurobehavioral TBI sequelae are important in reducing the severity of postinjury symptoms. Sequelae of TBI include cognitive impairments, personality changes, aggression, impulsivity, apathy, anxiety, depression, mania, and psychosis.


Donald Olson, MD

Latest:

Differentiating Epileptic Seizures From Other Spells

It can be difficult to determine whether unusual, paroxysmal behavior represents a seizure or a nonepileptic event. Patients with convulsive, clonic movements may, in fact, be experiencing psychogenic events.


Donald W. Black, MD

Latest:

Psychiatric Comorbidity Associated With Pathological Gambling

Gambling has become a major recreational activity in the United States. Formerly confined to a few states such as Nevada and New Jersey, legal gambling opportunities have exploded across the nation in the past 2 decades.


Donna A. Wirshing, MD

Latest:

Treatment Challenges in Schizophrenia: A Multifaceted Approach to Relapse Prevention

While an antipsychotic medication is the first step of treatment for schizophrenia, it is increasingly recognized that comprehensive care requires the integration of adjunctive therapies and attention to long-term treatment goals.


Donna M. Norris, MD

Latest:

6 Things to Remember When Practicing Telemedicine

What 6 things are important to keep telemedicine practice running smoothly?


Donna M. Sudak, MD

Latest:

Psychotherapy for Treatment-Resistant Depression Is Overlooked, Underused

"Evidence indicates that psychotherapy may yield greater durability of treatment gains than pharmacotherapy."


Donna Wirshing, MD

Latest:

Medicolegal Considerations in the Treatment of Psychosis With Second-Generation Antipsychotics

Are the metabolic side effects of the atypical antipsychotics fueling the next round of malpractice suits being filed against psychiatrists? Guidelines are being created, but how can clinicians protect themselves and their patients, while continuing to give their patients the best care available?


Dora Black, MD

Latest:

Coping When Mother Kills Father

In almost all cases where the mother kills the father, the mother has endured years of abuse at the hands of the father. Unfortunately, the children also suffer. How can psychiatrists help these children heal after such a tragedy?


Doriana Morar, MD

Latest:

Insights Into Mood and Cognitive Disability in MS: Recognition and Treatment

Depression and cognitive impairment are common in patients with multiple sclerosis (MS) but often are overlooked. These complications affect not only general quality of life but also complicate core symptoms of the disease. Depression in MS is well documented and easily treated while cognitive impairment sometimes needs a sharper eye to detect.


Doris Greenberg, MD

Latest:

Asperger Disorder: Gone But Not Forgotten

Although Asperger disorder is now included as part of the overall autism spectrum disorder, some say Pandora’s box has been opened.


Doris Iarovici, MD

Latest:

Perspectives on College Student Suicide

Loneliness, substance abuse, dating violence, and hopelessness, are just some of the risk factors for suicide, which remains the second leading cause of death for college students.


Doron Sagman, MD

Latest:

Comorbidity in Bipolar Disorder

The central tenet of clinical comorbidity, the occurrence of 2 syndromes in the same patient, presupposes that they are distinct categorical entities.


Dorothy P. Reddy, MD

Latest:

Treatment-Resistant Anxiety Disorders: Neurotrophic Perspectives

Anxiety disorders are the most prevalent psychiatric disorders in the United States. Although effective treatments are available, such as the SSRIs and cognitive-behavioral therapy (CBT), it is estimated that in about 40% of patients, anxiety disorders are partially or completely resistant to first-line treatment.


Dorothy Stubbe

Latest:

Child and Adolescent Psychiatry

One of the major challenges in child psychiatry is teaching the essentials of the field to the general physician or medical school student who needs some understanding of developmental issues and psychopathology. Dorothy Stubbe's contribution to this challenge is a small and well-written handbook published as part of the series, Practical Guides in Psychiatry.


Doug Berger, MD, PhD

Latest:

Cognitive Behavioral Therapy: Escape From the Binds of Tight Methodology

CBT has become rooted as proven dogma in the treatment of depression despite large problems remaining in methodology of CBT clinical trials and the logic behind how CBT works. This article will describe the major methodologic problems in the clinical trials of CBT.


Doug Drossman, MD

Latest:

Functional GI Disorders and Psychiatry

This article provides background information on the FGIDs for psychiatrists and a review of recent research on the biopsychosocial mechanisms that contribute to the illness experience.


Doug Puryear, MD

Latest:

An Alternative Approach To The Suicidal Patient: Crisis Intervention

There are currently several disturbing phenomena in the field of suicidology: •Many papers are describing risk assessment and suggesting the need for high-risk patients to be hospitalized. •Emergency department (ED) staff are complaining about spending much of their time trying to find beds for patients. •Programs are claiming “crisis intervention” when, in fact, they only provide triage.


Douglas A. Kramer, MD, MS

Latest:

Remembering: A Gentleman and a Psychiatrist

Johan Verhulst, MD, left this world exactly as he lived-with grace, honor, integrity, humor, love, humility, intellect, and a continuing interest in our ongoing professional conversations.

© 2024 MJH Life Sciences

All rights reserved.